Abstract
The blood-brain barrier (BBB) is a major challenge for the treatment of central nervous system (CNS) diseases. The BBB strictly regulates the movement of molecules into and out of the brain, and therefore protects the brain from noxious agents. However, for this reason the BBB also acts as a major obstacle that prevents most therapeutic molecules from getting into the target site of the brain. Therefore, it is essential to develop an efficient and general approach to overcome the BBB and transport the drug to the targeted region. Nanoparticle-based drug delivery systems are emerging as a promising drug delivery platform, due to their distinct advantages of tunable biophysical properties such as surface chemistry, size, and shape leading to various biological actions (like clearance, biodistribution, and biocompatibility) in the body. Therefore, it was hypothesized that the surface and shape of nanoparticles will influence their BBB permeation efficiency. Here, we describe a series of upconversion nanoparticles with different surfaces (oleic acid-free, DNA-modified, Silica coating, and PEG-encapsulated), PEGylated UCNPs with various shapes were generated (including sphere and rod). The cellular uptake ability, biodistribution, and BBB penetration of those UCNPs were assessed in cultured cells (NSC-34 neuron- like cells) and in vivo (zebrafish models).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Petros RA, Desimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615–627
Bogdan N, Vetrone F, Ozin GA, Capobianco JA (2011) Synthesis of ligand-free colloidally stable water dispersible brightly luminescent lanthanide-doped upconverting nanoparticles. Nano Lett 11:835–840
Champion JA, Katare YK, Mitragotri S (2007) Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release 121:3–9
Chen C, Duan Z, Yuan Y, Li R, Pang L, Liang J, Xu X, Wang J (2017) Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. ACS Appl Mater Interfaces 9:5864–5873
Kim JH, Kim JH, Kim KW, Kim MH, Yu YS (2009) Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology 20:505101
Cheng D, Shami GJ, Morsch M, Chung RS, Braet F (2016) Ultrastructural mapping of the zebrafish gastrointestinal system as a basis for experimental drug studies. Biomed Res Int 2016:1–13
Choi HS, Ipe BI, Misra P, Lee JH, Bawendi MG, Frangioni JV (2009) Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett 9:2354–2359
Don EK, Formella I, Badrock AP, Hall TE, Morsch M, Hortle E, Hogan A, Chow S, Gwee SSL, Stoddart JJ, Nicholson G, Chung R, Cole NJ (2017) A Tol2 gateway-compatible toolbox for the study of the nervous system and neurodegenerative disease. Zebrafish 14:69–72
Masserini M (2013) Nanoparticles for brain drug delivery. ISRN Biochem 2013:1–18
Ge X, Dong L, Sun L, Song Z, Wei R, Shi L, Chen H (2015) New nanoplatforms based on UCNPs linking with polyhedral oligomeric silsesquioxane (POSS) for multimodal bioimaging. Nanoscale 7:7206–7215
Gref R, Couvreur P, Barratt G, Mysiakine E (2003) Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 24:4529–4537
Haase M, Schäfer H (2011) Upconverting nanoparticles. Angew Chem Int Ed 50:5808–5829
Huang X, Teng X, Chen D, Tang F, He J (2010) The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31:438–448
Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 9:615–627
Kuang Y, An S, Guo Y, Huang S, Shao K, Liu Y, Li J, Ma H, Jiang C (2013) T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Int J Pharm 454:11–20
Kurakhmaeva KB, Djindjikhashvili IA, Petrov VE, Balabanyan VU, Voronina TA, Trofimov SS, Kreuter J, Gelperina S, Begley D, Alyautdin RN (2009) Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J Drug Target 17:564–574
Lin S, Li M, Dujardin E, Girard C, Mann S (2005) One-dimensional Plasmon coupling by facile self-assembly of gold nanoparticles into branched chain networks. Adv Mater 17:2553–2559
Lin YS, Haynes CL (2010) Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 132:4834–4842
Liu C, Gao Z, Zeng J, Hou Y, Fang F, Li Y, Qiao R, Shen L, Lei H, Yang W, Gao M (2013) Magnetic/upconversion fluorescent dual-modal molecular probes for imaging tiny tumors in vivo. ACS Nano 7:7227–7240
Liu D, Xu X, Du Y, Qin X, Zhang Y, Ma C, Wen S, Ren W, Goldys EM, Piper JA, Dou S, Liu X, Jin D (2016) Three-dimensional controlled growth of monodisperse sub-50 nm heterogeneous nanocrystals. Nat Commun 7:10254
Liu L, Venkatraman SS, Yang YY, Guo K, Lu J, He B, Moochhala S, Kan L (2008) Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Pept Sci 90:617–623
Lu J, Chen Y, Liu D, Ren W, Lu Y, Shi Y, Piper J, Paulsen I, Jin D (2015) One-step protein conjugation to upconversion nanoparticles. Anal Chem 87:10406–10413
Lu Y, Zhao J, Zhang R, Liu Y, Liu D, Goldys EM, Yang X, Xi P, Sunna A, Lu J, Shi Y, Leif RC, Huo Y, Shen J, Piper JA, Robinson JP, Jin D (2014) Tunable lifetime multiplexing using luminescent nanocrystals. Nat Photonics 8:32
Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379:146–157
Morsch M, Radford R, Lee A, Don EK, Badrock AP, Hall TE, Cole NJ, Chung R (2015) In vivo characterization of microglial engulfment of dying neurons in the zebrafish spinal cord. Front Cell Neurosci 9:321
Park J, Mattessich T, Jay SM, Agawu A, Saltzman WM, Fahmy TM (2011) Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates. J Control Release 56:109–115
Shi B, Zhang H, Qiao SZ, Bi J, Dai S (2014) Intracellular microenvironment-responsive label-free autofluorescent nanogels for traceable gene delivery. Adv Healthc Mater 3:1839–1848
Shi Y, Shi B, Dass AVE, Lu Y, Sayyadi N, Kautto L, Willows RD, Chung R, Piper J, Nevalainen H, Walsh B, Jin D, Packer NH (2016) Stable upconversion nanohybrid particles for specific prostate cancer cell immunodetection. Sci Rep 8:1–11
Singh SR, Grossniklaus HE, Kang SJ, Edelhauser HF, Ambati BK, Kompella UB (2009) Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther 16:645–659
Sun W, Xie C, Wang H, Hu Y (2004) Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials 25:3065–3071
Tang J, Kemp KW, Hoogland S, Jeong KS, Liu H, Levina L, Furukawa M, Wang X, Debnath R, Cha D, Chou KW, Fischer A, Amassian A, Asbury JB, Sargent EH (2011) Colloidal-quantum-dot photovoltaics using atomic-ligand passivation. Nat Mater 10:765–771
Wang F, Deng R, Liu X (2014) Preparation of core-shell NaGdF4 nanoparticles doped with luminescent lanthanide ions to be used as upconversion-based probes. Nat Protoc 9:1634–1644
Wang F, Liu X (2009) Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 38:976–989
Wang H, Zhang S, Liao Z, Wang C, Liu Y, Feng S, Jiang X, Chang J (2010) PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier. Biomaterials 31:6589–6596
Wong AC, Wright DW (2016) Size-dependent cellular uptake of DNA functionalized gold nanoparticles. Small 12:5592–5600
Yi DK, Selvan ST, Lee SS, Papaefthymiou GC, Kundaliya D, Ying JY (2005) Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J Am Chem Soc 127:4990–4991
Fu LB, Shi BY, Jin DY, Chung R (2017) A versatile upconversion surface evaluation platform for bio–nano surface selection for the nervous system. Nanoscale 9:13683–13692
Acknowledgments
This project has been supported by NHMRC grants awarded to R.C. (APP1095215) and B.S. (APP1111611).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Fu, L., Chung, R., Shi, B. (2019). Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease. In: Batra, J., Srinivasan, S. (eds) Theranostics. Methods in Molecular Biology, vol 2054. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9769-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9769-5_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9768-8
Online ISBN: 978-1-4939-9769-5
eBook Packages: Springer Protocols